✦ LIBER ✦

Self-administration of the D1agonist SKF 82958 is mediated by D1, not D2, receptors

✍ Scribed by D. W. Self; J. D. Belluzzi; S. Kossuth; L. Stein

Publisher: Springer
Year: 1996
Tongue: English
Weight: 446 KB
Volume: 123
Category: Article
ISSN: 0033-3158
DOI: 10.1007/bf02246638

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of dopamine synthesis in stri

Inhibition of dopamine synthesis in striatal slices by the D1 agonist SKF 38393 is not mediated by D1 dopamine receptors

✍ Richard J. Brooderson; Francis J. White; Dr. Mathew P. Galloway 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 335 KB

Enhancement of the acoustic startle resp

Enhancement of the acoustic startle response in rats by the dopamine D1 receptor agonist SKF 82958

✍ Edward G. Meloni; Michael Davis 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 107 KB

Self-administration of D1receptor agonis

Self-administration of D1receptor agonists by squirrel monkeys

✍ D. M. Grech; R. D. Spealman; J. Bergman 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 925 KB

Effects of chronic administration of the

Effects of chronic administration of the D1receptor partial agonist SKF 77434 on cocaine self-administration in rhesus monkeys

✍ Nicole H. Mutschler; Jack Bergman 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 128 KB

The substantia nigra pars reticulata med

The substantia nigra pars reticulata mediates the enhancement of startle by the dopamine D1receptor agonist SKF

✍ Edward G. Meloni; Michael Davis 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 286 KB

Antiparkinsonian effects of the novel D3

Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP-lesioned marmosets: Mediation by D2, not D3, dopamine receptors

✍ Michael P. Hill; Paula Ravenscroft; Steven G. McGuire; Jonathan M. Brotchie; Ala 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

L-dopa remains the most common treatment for Parkinson's disease. However, there is considerable interest in D3/D2 receptor agonists such as the novel agent S32504, since they exert antiparkinsonian properties in the absence of dyskinesia. An important question concerns the roles of D2 vs. D3 recept